Journal of Cancer Therapy

Journal of Cancer Therapy

ISSN Print: 2151-1934
ISSN Online: 2151-1942
www.scirp.org/journal/jct
E-mail: jct@scirp.org
"Low Dose of IL-12 Stimulates T Cell Response in Cultures of PBMCs Derived from Non Small Cell Lung Cancer Patients"
written by Lucia D’Amico, Enrico Ruffini, Riccardo Ferracini, Ilaria Roato,
published by Journal of Cancer Therapy, Vol.3 No.4A, 2012
has been cited by the following article(s):
  • Google Scholar
  • CrossRef
[1] Anti-Aging e Medicina Preventiva con Radio Electric Asymmetric Conveyer Technology
[2] The clinical and biological effects of homeopathically prepared signaling molecules: a scoping review
Homeopathy, 2022
[3] Immunohistochemical detection of pro-inflammatory and anti-inflammatory interleukins in the lungs of sheep with jaagsiekte
Turkish Journal of …, 2022
[4] Therapeutic and Prophylactic Use of Oral, Low-Dose IFNs in Species of Veterinary Interest: Back to the Future
2021
[5] Rationale and utility of sub-therapeutic/low dose cytokines and growth factors in dermatology: an overview
2020
[6] Psycho‐Neuro‐Endocrine‐Immunology: A Psychobiological Concept
2019
[7] Quarant'anni di acqua fresca: Una vita nell'omeopatia
2019
[8] LEISHMANIOSI CANINA− OVERLAPPING TERAPEUTICO CON CITOCHINE LOW DOSE NEL TRATTAMENTO DI 12 CASI
2019
[9] Highly Diluted Acetylcholine Promotes Wound Repair in an In Vivo Model
2018
[10] Low Dose Medicine: theoretical background and scientific evidence
2018
[11] Femtograms of Interferon-γ Suffice to Modulate the Behavior of Jurkat Cells: A New Light in Immunomodulation
International Journal of Molecular Sciences, 2017
[12] Psycho-Neuro-Endocrine-Immunology: A Psychobiological Concept
Ultraviolet Light in Human Health, Diseases and Environment?, 2017
[13] Metabolic Cardiology
Integrative Cardiology, 2017
[14] Low-Dose Therapy for the Treatment of Low-Grade Chronic Inflammation
Integrative Cardiology, 2017
[15] Adjuvant usage of parenteral infusions of vitamin C, glutathion and other substances in oncologic patients at InPHARM Clinic
2016
[16] New Frontiers in Vitiligo Treatment: The Low Dose Cytokines-Based Therapy
2016
[17] Clinical improvement in feline herpesvirus 1 infected cats by oral low dose of interleukin-12 plus interferon-gamma
Comparative Immunology, Microbiology and Infectious Diseases, 2016
[18] Skin as a Psychoneuroendocrine Immunology Microcosm: The New Frontier of Low Dose Therapy With Cytokines and Growth Factors in the Systemic Treatment of Chronic Autoimmune Inflammatory Diseases in Dermatology
Jentashapir Journal of Health Research, 2016
[19] Stimulation of the Nonneuronal Cholinergic System by Highly Diluted Acetylcholine in Keratinocytes
Cells Tissues Organs, 2016
[20] Skin as a Psychoneuroendocrine Immunology Microcosm: The New Frontier of Low Dose Therapy With Cytokines and Growth Factors in the Systemic Treatment of …
2016
[21] Skin as a Psychoneuroendocrine Immunology Microcosm: The New Frontier of Low Dose Therapy With Cytokines and Growth Factors in the Systemic …
2016
[22] La Balanced Scorecard nelle Aziende Sanitarie
2015
[23] Successful treatment of psoriasis with low-dose per os interleukins 4, 10, and 11.
2015
[24] Enhancement of the Immunostimulatory Functions of Ex Vivo–Generated Dendritic Cells from Early-Stage Colon Cancer Patients by Consecutive Exposure to …
Translational Oncology, 2015
[25] Treatment Options for Vitiligo
2015
[26] New Therapeutic Opportunities in Dermatology: Low Dose Cytokines Treatment for Vitiligo
2015
[27] New scenarios in dermatology psychoneuroendocrine immunology and the low-dose medicine approach
Pigment International, 2015
[28] Treatment with low-dose cytokines reduces oxidative-mediated injury in perilesional keratinocytes from vitiligo skin
2015
[29] Enhancement of the Immunostimulatory Functions of Ex Vivo–Generated Dendritic Cells from Early-Stage Colon Cancer Patients by Consecutive Exposure to Low Doses of Sequential-Kinetic-Activated IL-4 and IL-12. A Preliminary Study
Translational oncology, 2015
[30] Advances in the treatment options for vitiligo: activated low-dose cytokines-based therapy
Expert opinion on pharmacotherapy, 2015
[31] Erfolgreiche Kombinationsbehandlung der Psoriasis mit Phototherapie und niedrig dosierten Zytokinen
Der Hautarzt, 2015
[32] Successful treatment of psoriasis with low‐dose per os interleukins 4, 10, and 11
Dermatologic therapy, 2015
[33] NOVÉ MEDICÍNSKÉ PARADIGMA: MEDICÍNA NÍZKÝCH DÁVEK
2015
[34] Low dose cytokine and the psycho-neuro-endocrine-immune approach in dermatology: Here is the future
Glob Dermatol, 2015
[35] New Winning Strategies for Vitiligo: The Low Dose Cytokines Therapy Approach
2015
[36] Successful treatment of psoriasis with low-dose per os interleukins 4, 10, and 11
Dermatologic therapy, 2015
[37] Twenty-five years of studies and trials for the therapeutic application of IL-10 immunomodulating properties. From high doses administration to low dose medicine new paradigm
Journal of Integrative Cardiology, 2014
[38] Low-doses of sequential-kinetic-activated interferon-γ enhance the ex vivo cytotoxicity of peripheral blood natural killer cells from patients with early-stage colorectal cancer. A preliminary study
International immunopharmacology, 2014
[39] The History of Low Dose Medicine Research Review of Preclinical and Clinical Studies with Low Dose SKA Cytokines Since 2009
Interdiscip J Microinflammation, 2014
[40] Low-doses of sequential-kinetic-activated interferon-γ enhance the ex vivo cytotoxicity of peripheral blood natural killer cells from patients with early-stage colorectal …
International Immunopharmacology, 2014
[41] Twenty-five years of studies and trials for the therapeutic application of IL-10 immunomodulating properties. From high doses administration to low dose …
2014
[42] Comparison of ICSI outcome using microdose of G-CSF and IL-10
17TH WORLD CONGRESS ON CONTROVERSIES IN OBSTETRICS, GYNECOLOGY & INFERTILITY (COGI), 2013
[43] Comparison of ICSI out come using microdose of G-CSF and IL-10
2012
[44] Low Dose Medicine. La Medicina che Sussurra alle Cellule
Free SCIRP Newsletters
Copyright © 2006-2024 Scientific Research Publishing Inc. All Rights Reserved.
Top